756 top medical experts on Diabetic Nephropathies across 62 countries and 41 U.S. states, including 677 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Diabetic Nephropathies: kidney injuries associated with diabetes mellitus and affecting kidney glomerulus; arterioles; kidney tubules; and the interstitium. Clinical signs include persistent proteinuria, from microalbuminuria progressing to albuminuria of greater than 300 mg/24 h, leading to reduced glomerular filtration rate and END-stage renal disease.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Kidney Diseases (3,539), Diabetes Complications (4,287).
- Clinical Trials : at least 385 including 13 Active, 212 Completed, 51 Recruiting
- Synonyms: Diabetic Glomerulosclerosis, Diabetic Glomerulosclerosis
- Heerspink, Hiddo J LambersDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands .Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Renal Insufficiency, Chronic; Albuminuria; Benzhydryl CompoundsCategories: Therapeutic Use; Drug Therapy; Prevention & Control; Complications; Drug Effects; Administration & Dosage
- de, Zeeuw DickDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.Subjects: Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency, Chronic; Cardiovascular Diseases; Kidney Failure, ChronicCategories: Drug Therapy; Therapeutic Use; Prevention & Control; Complications; Metabolism; Blood
- Perkovic, VladoThe George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.Subjects: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Albuminuria; Sodium-Glucose Transporter 2 Inhibitors; Hypoglycemic AgentsCategories: Drug Therapy; Therapeutic Use; Prevention & Control; Complications; Etiology; Administration & Dosage
- Agarwal, Rajiv NephrologyRichard L. Roudebush VA Medical Center and Indiana University, Indianapolis, IN, USA.Disclosed payments in 2021 from 54 biomedical companies, totalling $105,037.04, including $80,747.33 from Bayer HealthCare Pharmaceuticals Inc.Subjects: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Albuminuria; Cardiovascular Diseases; Kidney Failure, ChronicCategories: Drug Therapy; Therapeutic Use; Metabolism; Complications; Prevention & Control; Administration & Dosage
- Charytan, David M NephrologyNephrology Division, New York University School of Medicine and New York University Langone Medical Center, New York, New York. Top HospitalMedical school: New York University School of Medicine (MD, 1998)Medicare AcceptedDisclosed payments in 2021 from 8 biomedical companies, totalling $11,988.4, including $3,520 from Novo Nordisk ASSubjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, ChronicCategories: Prevention & Control; Therapeutic Use; Drug Therapy; Diet Therapy; Drug Effects; Mortality
- Wheeler, David CDepartment of Renal Medicine, University College London, United Kingdom.Subjects: Sodium-Glucose Transporter 2 Inhibitors; Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Benzhydryl Compounds; Cardiovascular DiseasesCategories: Therapeutic Use; Drug Therapy; Prevention & Control; Complications; Epidemiology; Therapy
- Bhatt, Deepak L Interventional CardiologyBrigham and Womens Hospital Heart and Vascular Center Harvard Medical School Boston MA. Top HospitalMedical school: Js Weill Medical College, Cornell University (MD, 1993)Medicare AcceptedDisclosed payments in 2021 from 32 biomedical companies, totalling $169,114.48, including $51,540 from PFIZER INC.Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Cardiovascular Diseases; Adamantane; DipeptidesCategories: Drug Therapy; Therapeutic Use; Prevention & Control; Administration & Dosage; Analogs & Derivatives; Epidemiology
- Tuttle, Katherine R NephrologyDivision of Nephrology, Department of Medicine, University of Washington, & Providence Health Care, Spokane, Washington. Top HospitalMedical school: Other (MD, 2007)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 84.8/100Disclosed payments in 2021 from 23 biomedical companies, totalling $48,229.77, including $15,640 from Novo Nordisk ASSubjects: Diabetes Mellitus, Type 2; Kidney Failure, Chronic; Hypoglycemic Agents; Kidney; Renal Insufficiency, ChronicCategories: Drug Therapy; Therapeutic Use; Drug Effects; Metabolism; Mortality; Blood
- Jardine, Meg JThe George Institute for Global Health, UNSW, Sydney, Australia.Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, Chronic; AlbuminuriaCategories: Therapeutic Use; Prevention & Control; Drug Therapy; Etiology; Epidemiology; Complications
- Pollock, Carol ARenal Research Laboratory, Kolling Institute of Medical Research, University of Sydney, Sydney, NSW 2065, Australia.Subjects: Diabetes Mellitus, Experimental; Kidney Tubules, Proximal; Intermediate-Conductance Calcium-Activated Potassium Channels; Kidney; AlbuminuriaCategories: Metabolism; Drug Therapy; Therapeutic Use; Genetics; Pathology; Pharmacology
- Neal, BruceThe George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, Chronic; Renal Insufficiency, ChronicCategories: Drug Therapy; Prevention & Control; Therapeutic Use; Metabolism; Blood; Administration & Dosage
- Nelson, Robert G Internal MedicineChronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.Subjects: Diabetes Mellitus, Type 2; Kidney Failure, Chronic; Diabetes Mellitus, Type 1; Indians, North American; KidneyCategories: Genetics; Metabolism; Blood; Pathology; Physiopathology; Complications
- Levin, AdeeraDivision of Nephrology, University of British Columbia, Vancouver, BC, Canada A.L..Subjects: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, ChronicCategories: Therapeutic Use; Drug Therapy; Prevention & Control; Complications; Diet Therapy; Drug Effects
- Kretzler, Matthias NephrologyDivision of Nephrology, University of Michigan, Ann Arbor, MI.Medical school: Other (MD, 1992)Medicare AcceptedDisclosed payments in 2021 from 3 biomedical companies, totalling $7,150, including $4,470 from Gilead Sciences, Inc.Subjects: Diabetes Mellitus, Type 2; Podocytes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Experimental; AlbuminuriaCategories: Metabolism; Genetics; Physiology; Blood; Pathology; Complications
- Leiter, Lawrence ALi Ka Shing Knowledge Institute, St Michaels Hospital, University of Toronto, Toronto, ON, Canada.Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Hypoglycemic Agents; Renal Insufficiency; Sodium-Glucose Transporter 2 InhibitorsCategories: Drug Therapy; Therapeutic Use; Prevention & Control; Epidemiology; Administration & Dosage; Analogs & Derivatives
- Cooper, Mark EDepartment of Diabetes, Central Clinical School, Monash University, Melbourne, Australia.Subjects: Diabetes Mellitus, Type 2; Kidney; Albuminuria; Diabetes Mellitus, Experimental; Renal Insufficiency, ChronicCategories: Metabolism; Drug Therapy; Therapeutic Use; Prevention & Control; Complications; Genetics
- Mosenzon, OfriDiabetes Unit and Endocrine Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Cardiovascular Diseases; Renal Insufficiency; AdamantaneCategories: Drug Therapy; Therapeutic Use; Prevention & Control; Administration & Dosage; Analogs & Derivatives; Complications
- Wanner, ChristophMedizinische Klinik und Poliklinik 1, Schwerpunkt Nephrologie, Universitätsklinik Würzburg, Würzburg, Germany.Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Renal Insufficiency, Chronic; Kidney Failure, Chronic; Benzhydryl CompoundsCategories: Therapeutic Use; Drug Therapy; Therapy; Blood; Mortality; Complications
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.